Clinical Trial Update: Effect of Lithium Carbonate on Low-Dose Radioiodine Therapy in Early Thyroid Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating whether adding lithium carbonate to low-dose radioiodine therapy improves outcomes in early thyroid cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Differentiated Thyroid Carcinoma
• Thyroid Cancer

Drugs mentioned

• Lithium carbonate (Lithium carbonate)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Thyroid Cancer, Differentiated Thyroid Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2012-12-27